OX40 costimulator (Hyamab Pharmaceutical/Shanghai ChemPartner)

N/A

Report date: 2025/03/19 11:44:20

Base Information

Drug NameOX40 costimulator (Hyamab Pharmaceutical/Shanghai ChemPartner)
Drug Alias Nameagonistic anti-OX40 antibody (Shanghai ChemPartner/Hyamab Pharmaceutical)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Huaiyu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Chem Partner Co LtdJiangsu Huaiyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A